Novel biomarkers for risk stratification in pulmonary arterial hypertension - Wikidata - wikimedia - TriplyDB

Novel biomarkers for risk stratification in pulmonary arterial hypertension

Novel biomarkers for risk stratification in pulmonary arterial hypertension

http://www.wikidata.org/entity/Q28596829

about

Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?

P2860

Q47860759-C3E28031-BA48-4936-9365-B9373C15B939

P2860

Novel biomarkers for risk stratification in pulmonary arterial hypertension

http://www.wikidata.org/entity/Q28596829

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@ast

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@en

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@nl

type

label

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@ast

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@en

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@nl

prefLabel

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@ast

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@en

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@nl

P1433

Q28596829-D9A0D93F-0767-4A0C-9B6C-7712D7736CF1

P1476

Q28596829-0DABE768-2CB1-493D-91EA-2ABF2B16CCE0

P2093

Q28596829-0066C83B-E117-47E7-8EF0-E17150D7AA36

Q28596829-353F0B5C-2168-406A-8232-81079FC4C868

Q28596829-49E07A00-3880-42A7-B8B6-3F909A177A86

Q28596829-5504A978-BC9C-431E-949B-42046F4A8095

Q28596829-55ED4F58-5A03-4C47-818E-870F8520B5FC

Q28596829-667DE1A1-8FEB-4B2A-B93D-053B68EEF3A0

Q28596829-8A672548-D818-4DC2-A47F-C3111BBB27F3

Q28596829-8F3385E9-9E7F-4E09-BBAF-A92BF8170949

P2860

Q28596829-08ADDB68-69EF-47C4-B600-3C1EB93E09AB

Q28596829-0BF3BB0D-DB57-4B26-B5CF-E7A68F7EED6E

Q28596829-0F086873-ADB0-4FC7-94A8-DCEA1FCE5292

Q28596829-22A65B82-0794-4FE6-A118-25E02CAC33E3

Q28596829-2FE97142-61FA-44B2-B81C-866B1A33BC8F

Q28596829-3A8A079A-7267-4D27-B51C-E70FC4BB902D

Q28596829-47FE946D-57CC-4935-AC2F-5EAFF2DBF828

Q28596829-57226047-DE82-47A2-91F8-4CFB0A28BA7A

Q28596829-5DCF337B-5700-45FD-9969-FC74675D8E0E

Q28596829-5EE11099-D142-47A6-815F-EB5B6E9EC199

P304

Q28596829-70FFEBCF-ACB7-4DE9-AF8A-D9AF8E1FF601

P31

Q28596829-C61B9C1C-85BE-4B89-94EF-36F186E95C65

P356

Q28596829-62F07218-FA29-4118-ACCE-13CAD507495F

P407

Q28596829-B7EBFAB3-A5D1-44CC-8A36-BFB71A037F21

P433

Q28596829-4DE1941F-1061-48B8-AF39-F6BF1ABFF0F7

P478

Q28596829-C90461DA-EB33-4532-9D08-A9AD179ABD4A

P577

Q28596829-27FC3BF5-9D81-4C2C-BB6A-75F28B7FF65C

P5875

Q28596829-2F668848-B58A-45DF-92CF-6276B44D49B6

P698

Q28596829-85B855AC-AAB6-4E18-BB79-43EB209B15EF

P921

Q28596829-245449F6-0EF1-4C18-9BDC-E56944BD0AC6

Q28596829-CD40BEC2-38CB-4118-9195-681B372FA2C8

P932

Q28596829-352F2EA4-AB02-473D-941B-610656675863

P356

23120541.00008-2015

P1433

ERJ open research

P1476

Novel biomarkers for risk stratification in pulmonary arterial hypertension

@en

P2093

Evangelos Giannitsis

http://www.w3.org/2001/XMLSchema#string

Franz J Meyer

http://www.w3.org/2001/XMLSchema#string

Hugo A Katus

http://www.w3.org/2001/XMLSchema#string

Jörg Friedrich

http://www.w3.org/2001/XMLSchema#string

Lorenz Uhlmann

http://www.w3.org/2001/XMLSchema#string

Michael R Preusch

http://www.w3.org/2001/XMLSchema#string

Sebastian Spaich

http://www.w3.org/2001/XMLSchema#string

Thomas Zelniker

http://www.w3.org/2001/XMLSchema#string

P2860

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

Treatment goals of pulmonary hypertension

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Sildenafil citrate therapy for pulmonary arterial hypertension.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

P304

00008-2015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/23120541.00008-2015

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283670134

http://www.w3.org/2001/XMLSchema#string

P698

27730146

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

5005111

http://www.w3.org/2001/XMLSchema#string